🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, single-arm, phase II clinical study designed to obs...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-30
Trial ID
NCT06508229
Treatments Being Tested
To evaluate the efficacy and safety of apatinib combined with adebrelizumab...
Status
Not Yet Recruiting
Location
Fujian Cancer Hospital
Start Date
2025-01-25
Trial ID
NCT06786312
Treatments Being Tested
To evaluate the efficacy and safety of maintenance therapy with Adebrelimab...
Status
Recruiting
Location
The First Hospital of China Medical University
Start Date
2024-08-09
Trial ID
NCT06480864
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Chinese People's Liberation Army General Hospital
Start Date
2024-07-30
Trial ID
NCT06512051
This is a Phase II clinical study to evaluate the efficacy and safety of SH...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06480136
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2024-06-20
Trial ID
NCT06474468
Treatments Being Tested
This is a prospective, single-arm study to investigate the efficacy and saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-15
Trial ID
NCT06299371
Treatments Being Tested
The purpose of this observational study is to evaluate the safety and effic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-01
Trial ID
NCT06530797
This study plans to enroll limited-stage small cell lung cancer (LS-SCLC) p...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2026-01-31
Trial ID
NCT07357532
Treatments Being Tested
In phase II, the main objective is to evaluate the efficacy of SHR-A2102 co...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-25
Trial ID
NCT06879145
Treatments Being Tested